G
GlucoTrack, Inc. (GCTK)
NCM – Real vaqt narxi. Valyuta: USD
0.38
+0.01 (1.37%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
0.38
-0.00 (-0.11%)
Bozordan keyin: Aug 12, 2026, 6:36 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.38
+0.01 (1.37%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
0.38
-0.00 (-0.11%)
Bozordan keyin: Aug 12, 2026, 6:36 PM EDT
GlucoTrack, Inc., tibbiy uskuna ishlab chiqaruvchi kompaniya, Qo'shma Shtatlarda diabetga chalinganlar uchun implantatsiya qilinadigan doimiy qon glyukozasi monitorini (CBGM) ishlab chiqishga qaratilgan. Kompaniya GlucoTrack CBGMni ishlab chiqaradi, bu 1-toifa diabetga chalinganlar va insulin-bog'liq 2-toifa diabetga chalinganlar uchun mo'ljallangan uzoq muddatli implantatsiya qilinadigan qon asosidagi CBGMdir. Kompaniya ilgari Integrity Applications, Inc. nomi bilan tanilgan va 2021-yil noyabr oyida GlucoTrack, Inc. nomini o'zgartirgan. GlucoTrack, Inc. 2001-yilda tashkil etilgan va Nyu-Jersi shtatining Rutherford shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Mark Tapsak Ph.D. | Chief Scientific Officer |
| Dr. Paul V. Goode Ph.D. | Chief Technical Officer, President & Director |
| Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus & Consultant |
| Mr. David Malka BA | Co-Founder |
| Mr. Erik C. Emerson | CEO & Director |
| Mr. Vincent Wong | Chief Operations Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-10 | DEF 14A | formdef14a.htm |
| 2026-08-05 | 8-K | form8-k.htm |
| 2026-07-31 | PRE 14A | formpre14a.htm |
| 2026-07-30 | 8-K | form8-k.htm |
| 2026-07-29 | 8-K/A | form8-ka.htm |
| 2026-07-27 | 8-K | form8-k.htm |
| 2026-07-17 | DEF 14A | formdef14a.htm |
| 2026-07-17 | ARS | formars.pdf |
| 2026-07-15 | 8-K | form8-k.htm |
| 2026-06-17 | PRE 14A | formpre14a.htm |
| Ms. Drinda Benjamin | Chief Commercial Officer |